Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |